143 related articles for article (PubMed ID: 18418008)
1. Pulmonary carcinoid tumours: indolent but not benign.
De Dosso S; Bajetta E; Procopio G; Cortinovis D; Buzzoni R; Catena L; Platania M; Verzoni E
Oncology; 2007; 73(3-4):162-8. PubMed ID: 18418008
[TBL] [Abstract][Full Text] [Related]
2. Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy.
Wirth LJ; Carter MR; Jänne PA; Johnson BE
Lung Cancer; 2004 May; 44(2):213-20. PubMed ID: 15084386
[TBL] [Abstract][Full Text] [Related]
3. [Surgical treatment of pulmonary carcinoids - ten-year results].
Vodicka J; Spidlen V; Klecka J; Simanek V; Safranek J; Mukensnabl P
Zentralbl Chir; 2011 Dec; 136(6):598-603. PubMed ID: 21786224
[TBL] [Abstract][Full Text] [Related]
4. [Bronchopulmonary carcinoids: surgical therapy and prognosis].
Huwer H; Kalweit G; Krüger B; Straub U; Schäfers HJ
Pneumologie; 1996 Nov; 50(11):786-9. PubMed ID: 9082447
[TBL] [Abstract][Full Text] [Related]
5. [Typical and atypical pulmonary carcinoids--pathologic and clinical analysis of 77 cases].
Słodkowska J; Langfort R; Rudziński P; Kupis W
Pneumonol Alergol Pol; 1998; 66(5-6):297-303. PubMed ID: 9857650
[TBL] [Abstract][Full Text] [Related]
6. Surgical management and palliative treatment in bronchial neuroendocrine tumours: a clinical study of 45 patients.
Srirajaskanthan R; Toumpanakis C; Karpathakis A; Marelli L; Quigley AM; Dusmet M; Meyer T; Caplin ME
Lung Cancer; 2009 Jul; 65(1):68-73. PubMed ID: 19070398
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
[TBL] [Abstract][Full Text] [Related]
8. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung.
García-Yuste M; Matilla JM; Cueto A; Paniagua JM; Ramos G; Cañizares MA; Muguruza I;
Eur J Cardiothorac Surg; 2007 Feb; 31(2):192-7. PubMed ID: 17196822
[TBL] [Abstract][Full Text] [Related]
9. [Histology does not accurately predict the clinical behaviour of bronchopulmonary carcinoids - results from an Icelandic population-based study].
Sigurdardottir JM; Isaksson HJ; Johannsson KB; Jonsson S; Gudbjartsson T
Laeknabladid; 2008 Feb; 94(2):125-30. PubMed ID: 18310777
[TBL] [Abstract][Full Text] [Related]
10. Bronchial carcinoid tumors: nodal status and long-term survival after resection.
Cardillo G; Sera F; Di Martino M; Graziano P; Giunti R; Carbone L; Facciolo F; Martelli M
Ann Thorac Surg; 2004 May; 77(5):1781-5. PubMed ID: 15111186
[TBL] [Abstract][Full Text] [Related]
11. Outcome of locally recurrent and metastatic angiosarcoma.
Lahat G; Dhuka AR; Lahat S; Smith KD; Pollock RE; Hunt KK; Ravi V; Lazar AJ; Lev D
Ann Surg Oncol; 2009 Sep; 16(9):2502-9. PubMed ID: 19551444
[TBL] [Abstract][Full Text] [Related]
12. Early outcomes of soft tissue sarcomas presenting with metastases and treated with chemotherapy.
King JJ; Fayssoux RS; Lackman RD; Ogilvie CM
Am J Clin Oncol; 2009 Jun; 32(3):308-13. PubMed ID: 19433963
[TBL] [Abstract][Full Text] [Related]
13. Typical and atypical carcinoids within the pulmonary APUD tumor spectrum.
DeCaro LF; Paladugu R; Benfield JR; Lovisatti L; Pak H; Teplitz RL
J Thorac Cardiovasc Surg; 1983 Oct; 86(4):528-36. PubMed ID: 6621081
[TBL] [Abstract][Full Text] [Related]
14. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S
J BUON; 2009; 14(2):203-9. PubMed ID: 19650167
[TBL] [Abstract][Full Text] [Related]
15. Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy.
Germain F; Wai ES; Berthelet E; Truong PT; Lesperance M
Am J Clin Oncol; 2008 Dec; 31(6):561-6. PubMed ID: 19060588
[TBL] [Abstract][Full Text] [Related]
16. Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer.
Xiong HQ; Varadhachary GR; Blais JC; Hess KR; Abbruzzese JL; Wolff RA
Cancer; 2008 Oct; 113(8):2046-52. PubMed ID: 18756532
[TBL] [Abstract][Full Text] [Related]
17. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
Hsu FM; Lin CC; Lee JM; Chang YL; Hsu CH; Tsai YC; Lee YC; Cheng JC
J Surg Oncol; 2008 Jul; 98(1):34-41. PubMed ID: 18449912
[TBL] [Abstract][Full Text] [Related]
18. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
19. [Carcinoid of trachea and bronchus: a report of 20 cases].
Wang Y; Wang L; Zhang D
Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):70-2. PubMed ID: 11783076
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome study.
Matsumoto S; Nishimura T; Kanai M; Mori Y; Nagayama S; Kawamura J; Nomura A; Miyamoto S; Kitano T; Ishiguro H; Yanagihara K; Teramukai S; Sakai Y; Chiba T; Fukushima M
Chemotherapy; 2008; 54(5):395-403. PubMed ID: 18781065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
